Key Takeaways The rapid rise of GLP-1 type weight-loss medications has transformed obesity treatment in the U.S., driven by pharmaceutical innovation and the expansion of telehealth, direct-to-consumer (DTC) healthcare platforms, and compounding pharmacies. How Telehealth Is Expanding GLP-1 Weight Loss Treatment A recent JMIR report highlighted how digital health platforms and evolving healthcare policies are […]
Key Takeaways The rapid rise of GLP-1 type weight-loss medications has transformed obesity treatment in the U.S., driven by pharmaceutical innovation and the expansion of telehealth, direct-to-consumer (DTC) healthcare platforms, and compounding pharmacies. How Telehealth Is Expanding GLP-1 Weight Loss Treatment A recent JMIR report highlighted how digital health platforms and evolving healthcare policies are […]
